Showing 1-10 of 570 news items

Patient and nurse

The Francis Report and our Trust values

31 March 2014

An overview of The Francis Report and what it means for us.

Professor Nazneen Rahman

Professor Nazneen Rahman makes Woman's Hour Power List

09 April 2014

Congratulations to Professor Nazneen Rahman who has been named in the top 10 of BBC Radio 4's Woman's Hour Power List.

Five women making a difference in medical research, treatment and care

08 March 2014

The Royal Marsden is proud of all of our world-class researchers and clinicians. For International Women’s Day, we highlight just five of the many women at the forefront of medical research, treatment and care.

James Larkin

The Royal Marsden leads the largest melanoma trial

26 February 2014

The Royal Marsden has led the biggest ever international study in malignant melanoma, the most aggressive form of skin cancer.

New breast cancer treatment trialed at The Royal Marsden given green light by regulators

13 February 2014

Kadcyla is now available for patients with advanced HER2-positive breast cancer via the Cancer Drugs Fund.

First ever UK Centres of Excellence in prostate cancer research launched

13 February 2014

The world-class Movember Centres of Excellence Programme in partnership with Prostate Cancer UK will see an injection of £10 million over a five year period.

David Cunningham

New drug combination offers improved metastatic pancreatic cancer survival

07 February 2014

Abraxane® in combination with standard chemotherapy gemcitabine has shown the greatest improvement in survival of any licensed treatment for metastatic pancreatic cancer in 17 years.

New agreement to support Colchester cancer services

03 February 2014

The Royal Marsden will provide support to Colchester Hospital University NHS Foundation Trust, which is currently in special measures.

A new pathway for cancer gene testing successfully completes pilot

22 January 2014

The Royal Marsden has completed a six-month pilot of a new ‘oncogenetic’ gene testing pathway which is much faster and less costly than standard gene testing pathways. More than 100 Royal Marsden cancer patients have now benefitted from BRCA1 and BRCA2 gene tests through the new pathway since the pilot began in July 2013.

Xofigo (Radium 223) launches in the UK

13 January 2014

A new drug trialled at The Royal Marsden for men with advanced prostate cancer has been given approval for use in the UK.

Showing 1-10 of 570 news items

Page printed from

Life demands excellenceNHSThe Institute of Cancer ResearchPositive About Disabled PeopleBSI logoCustomer Service ExcellenceRoyal Marsden Crest